EUVIMEDEUVIMED entdecken
Open Access

Respiratory Outcomes in Children With Neonatal Respiratory Distress Syndrome and Monoallelic ABCA3 Variants

Velda Ocasio Ramírez iD, Jennifer A Wambach, Rebekah J Nevel, Laura Voss, Daniel Craven iD, Alicia Casey, Devaney Camburn, Steven K Brennan, Whitney Bour Eldridge, F Sessions Cole, Gail H Deutsch, Michael W Kuzniewicz und 3 weitere

Pediatric Pulmonology · 2026-06 · 61 (6)

DOI: 10.1002/ppul.71695 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Pulmonology, online erschienen am 15.06.2026. Verfasst von Velda Ocasio Ramírez und 14 weiteren Autor:innen. Beteiligte Einrichtung: Eudowood Division of Pediatric Respiratory Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Respiratory Distress Syndrome, Newborn, ATP-Binding Cassette Transporters. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Lung disease due to ABCA3 variants and resultant surfactant dysfunction is an autosomal recessive disease. However, monoallelic ABCA3 variants are overrepresented in term or late‐preterm infants with non‐fatal neonatal respiratory distress syndrome (RDS). The childhood respiratory outcomes of infants with monoallelic ABCA3 variants who present with neonatal RDS are unknown. In this study, we report the respiratory outcomes beyond neonatal hospitalization (median follow‐up 1 year [range 1–9.4 years]) for infants with monoallelic ABCA3 variants and neonatal RDS.

Methods

Participants with monoallelic ABCA3 variants classified as pathogenic, likely pathogenic, or of uncertain significance with neonatal RDS identified in 3 cohorts (ChILD Registry n = 9, disease‐based cohort n = 19, and nested case‐control n = 20) were included in this retrospective, descriptive study. The primary outcome was duration of supplemental oxygen use. Secondary outcomes included respiratory morbidities after NICU discharge.

Results

Of 48 infants who met inclusion criteria, 8 (17%) were discharged home on supplemental oxygen, including two who required home invasive mechanical ventilation. The ABCA3 pathogenic variant p.Glu292Val was the most common variant identified in the infants who required oxygen beyond NICU discharge (6 of 8). Oxygen was discontinued by 10 months of age in 50% of infants discharged from birth hospitalization on oxygen. Respiratory morbidities, including hospitalizations (62% vs. 8%, p = 0.005) and emergency department (ED) visits (71% vs. 35%, p < 0.01), were more common among participants discharged home on oxygen compared to those discharged home without oxygen.

Conclusions

These findings suggest that infants with monoallelic ABCA3 variants and neonatal RDS may require prolonged home oxygen or mechanical ventilation and experience increased risk for respiratory morbidities, including subsequent hospitalization and ED visits.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Respiratory Distress Syndrome, NewbornATP-Binding Cassette TransportersHumansFemaleInfant, NewbornMaleRetrospective StudiesInfantCase-Control StudiesRespiration, ArtificialChildOxygen Inhalation TherapyFollow-Up Studies

Substanzen

ABCA3 protein, humanATP-Binding Cassette Transporters

Autor:innen und Institutionen

  • Eudowood Division of Pediatric Respiratory Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Edward Mallinckrodt Department of Pediatrics, Washington University School of Medicine, St. Louis Children's Hospital, Saint Louis, Missouri, USA.
  • Child Health, Division of Pediatric Pulmonary Medicine, University of Missouri, Columbia, Missouri, USA.
  • Department of Pediatrics, Division of Pulmonary and Sleep Medicine, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
  • Pediatric Pulmonology, Rainbow Babies and Children's Hospital, Cleveland, Ohio, USA.
  • Division of Pulmonary Medicine, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

ORCID-Profile: Velda Ocasio Ramírez, Daniel Craven, Lisa R Young, Lawrence Nogee, S Christy Sadreameli

Förderung

  • NHLBI NIH HHS
  • NCATS NIH HHS

Zitieren

APA

Ramírez, V. O., Wambach, J. A., Nevel, R. J., Voss, L., Craven, D., Casey, A., Camburn, D., Brennan, S. K., Eldridge, W. B., Cole, F. S., Deutsch, G. H., Kuzniewicz, M. W., Young, L. R., Nogee, L., & Sadreameli, S. C. (2026). Respiratory Outcomes in Children With Neonatal Respiratory Distress Syndrome and Monoallelic ABCA3 Variants. Pediatric Pulmonology, 61(6). https://doi.org/10.1002/ppul.71695

Vancouver

Ramírez VO, Wambach JA, Nevel RJ, Voss L, Craven D, Casey A, et al. Respiratory Outcomes in Children With Neonatal Respiratory Distress Syndrome and Monoallelic ABCA3 Variants. Pediatric Pulmonology. 2026;61(6). doi:10.1002/ppul.71695

BibTeX
@article{Ramrez2026,
  author = {Ramírez, Velda Ocasio and Wambach, Jennifer A and Nevel, Rebekah J and Voss, Laura and Craven, Daniel and Casey, Alicia and Camburn, Devaney and Brennan, Steven K and Eldridge, Whitney Bour and Cole, F Sessions and Deutsch, Gail H and Kuzniewicz, Michael W and Young, Lisa R and Nogee, Lawrence and Sadreameli, S Christy},
  title = {Respiratory Outcomes in Children With Neonatal Respiratory Distress Syndrome and Monoallelic ABCA3 Variants},
  journal = {Pediatric Pulmonology},
  year = {2026},
  volume = {61},
  number = {6},
  doi = {10.1002/ppul.71695}
}
Kostenlos starten →